Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression

By Wirth M.   Tyrrell C.   Wallace M.   Delaere K.P.   Sanchez-Chapado M.   Ramon J.   Hetherington J.   Pina F.   Heynes C.F.   Borchers T.M.   Morris T.   Stone A.  

Urology, Vol. 58, Iss. 2, 2001-08 ,pp. : 146-150

Elsevier

Access to resources Recommend Favorite

Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer

By Crnalic Sead   Hildingsson Christer   Wikström Pernilla   Bergh Anders   Löfvenberg Richard   Widmark Anders  

Acta Orthopaedica, Vol. 83, Iss. 1, 2012-02 ,pp. : 80-86

Informa Healthcare

Access to resources Recommend Favorite

Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status

By Moreno J.G.   O'Hara S.M.   Gross S.   Doyle G.   Fritsche H.   Gomella L.G.   Terstappen L.W.M.M.  

Urology, Vol. 58, Iss. 3, 2001-09 ,pp. : 386-392

Elsevier

Access to resources Recommend Favorite

Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer

By Dillioglugil O.   Leibman B.D.   Kattan M.W.   Seale-Hawkins C.   Wheeler T.M.   Scardino P.T.  

Urology, Vol. 50, Iss. 1, 1997-07 ,pp. : 93-99

Elsevier

Access to resources Recommend Favorite

Clinical states in prostate cancer: toward a dynamic model of disease progression

By Scher H.I.   Heller G.  

Urology, Vol. 55, Iss. 3, 2000-03 ,pp. : 323-327

Elsevier

Access to resources Recommend Favorite